A
Alcista
Alcista · 25%TDAC
$9.29
Precio del escenario
$10.910
+0.050 (+0.46%)Al cierre
Loading chart…
- Máximo
- 10.910
- Apertura
- 10.910
- Precio medio ponderado por volumen
- 10.91
- Volumen
- 315.00
- Capitalización
- —
- Mínimo
- 10.910
- Importe
- 3.44K
- EV/EBITDA, TTM
- 0.00
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
Análisis de IA of Translational Development Acquisition Corp (TDAC)
ComprarTDAC is a good buy right now due to its recent merger with ProLogium, which has a pre-money valuation of $3.8 billion, indicating significant growth potential. The stock is currently priced at $10.83, which is 77.8% of its 52-week range, suggesting it is near its high. Additionally, the RSI is at 48.77, indicating it is not overbought, which is favorable for entry. However, the main risk is the current ratio of 0.06, indicating potential liquidity issues in the near term.
Métricas de valoración
El PER previsto actual de Translational Development Acquisition Corp (TDAC) es 0.00, frente a su media de 5 años de 0.00.
Escenarios de precio de Alphio AI para TDAC
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
5.010-30NewsfilterProLogium Appoints New Independent Director
- 8.510-12Newsfilter
ProLogium Advances Collaboration with Rimac on EV Battery Development
- 8.509-09Newsfilter
ProLogium Deepens Strategic Partnership with Kyushu Electric Power
- 8.508-24Newsfilter
ProLogium Appoints Rimac CEO to Board Amid Growth Phase
- 8.507-28Newsfilter
ProLogium Secures $50 Million Investment for Growth
Preguntas frecuentes sobre TDAC, respondidas por Alphio AI
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.
TDAC is a good buy right now due to its recent merger with ProLogium, which has a pre-money valuation of $3.8 billion, indicating significant growth potential. The stock is currently priced at $10.83, which is 77.8% of its 52-week range, suggesting it is near its high. Additionally, the RSI is at 48.77, indicating it is not overbought, which is favorable for entry. However, the main risk is the current ratio of 0.06, indicating potential liquidity issues in the near term.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarArtículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.